Hiroko Hasegawa
- Oncology top 10%
- Colorectal Cancer Treatments and Studies 26
- Cancer Treatment and Pharmacology 10
- Rehabilitation top 10%
- Complementary and Manual Therapy top 10%
-
- Gastric Cancer Management and Outcomes 19
- Metastasis and carcinoma case studies 8
-
- Gastrointestinal Tumor Research and Treatment 7
-
- Cancer Genomics and Diagnostics 9
-
- Steroid Chemistry and Biochemistry 7
-
- Cardiac Valve Diseases and Treatments 6
- Co-authors
- Katsuhiko SuzukiKyosuke TsudaShigeo KatsumuraTetsuya YamamotoToshikazu HakogiShigeyuki NakajiYoshihiro SatōToshihiko Okamoto
- Journals
- Journal of Clinical Oncology (11 papers)Chemical and Pharmaceutical Bulletin (9 papers)Annals of Oncology (6 papers)
- Partner nations
- JapanUnited StatesBelgium
In The Last Decade
Hiroko Hasegawa
87 papers receiving 874 citations
Peers
Comparison fields: 5 of 105
- Oncology 245
- Rehabilitation 58
- Complementary and Manual Therapy 15
- Pulmonary and Respiratory Medicine 213
- Gastroenterology 29
Countries citing papers authored by Hiroko Hasegawa
This map shows the geographic impact of Hiroko Hasegawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Hasegawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Hasegawa more than expected).
Fields of papers citing papers by Hiroko Hasegawa
This network shows the impact of papers produced by Hiroko Hasegawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Hasegawa. The network helps show where Hiroko Hasegawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroko Hasegawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 3 | |
| 9 | 2020 | 5 | |
| 10 | 2019 | 4 | |
| 11 | 2018 | 9 | |
| 12 | 2017 | 6 | |
| 13 | 2015 | 0 | |
| 14 | 2013 | 5 | |
| 15 | 2012 | 8 | |
| 16 | 2010 | 11 | |
| 17 | 2010 | 7 | |
| 18 | 2010 | 51 | |
| 19 | 2009 | 3 | |
| 20 | [Dietary patterns and intake of nutrients, energy, and dietary fiber in medical students]. | 1996 | 0 |
About Hiroko Hasegawa
Hiroko Hasegawa is a scholar working on Gastroenterology, Oncology and Pulmonary and Respiratory Medicine, having authored 99 papers that have together received 905 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (26 papers), Gastric Cancer Management and Outcomes (19 papers), Cancer Treatment and Pharmacology (10 papers), Cancer Genomics and Diagnostics (9 papers), Metastasis and carcinoma case studies (8 papers), Gastrointestinal Tumor Research and Treatment (7 papers), Steroid Chemistry and Biochemistry (7 papers) and Cardiac Valve Diseases and Treatments (6 papers). The work is most often cited by research in Oncology (245 citations), Rehabilitation (58 citations) and Complementary and Manual Therapy (15 citations). Hiroko Hasegawa has collaborated with scholars based in Japan, United States and Belgium. Frequent co-authors include Katsuhiko Suzuki, Kyosuke Tsuda, Shigeo Katsumura, Tetsuya Yamamoto, Toshikazu Hakogi, Shigeyuki Nakaji, Yoshihiro Satō, Toshihiko Okamoto, Yutaka Kawazoe and Mitsutaka Natsume. Their work appears in journals such as Journal of Clinical Oncology, Chemical and Pharmaceutical Bulletin, Annals of Oncology, Chemistry Letters and Hepatology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.